ARMP
Armata Pharmaceuticals Inc (ARMP)
Healthcare • NYSE MKT • $3.37+9.06%
- Symbol
- ARMP
- Exchange
- NYSE MKT
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $3.37
- Daily Change
- +9.06%
- Market Cap
- $125.30M
- Trailing P/E
- N/A
- Forward P/E
- -1.65
- 52W High
- $16.34
- 52W Low
- $2.75
- Analyst Target
- $17.50
- Dividend Yield
- 0.00%
- Beta
- 1.41
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
Company websiteResearch ARMP on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.